and is looking to expand its Pipeline Commercialization capability by bringing on a Sr. Manager to support strategic initiatives across various... and will report to the global commercial lead of Zilebesiran. They will support Zilebesiran, Alnylam’s flagship program...
diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach.... Precision Medicine Program Manager (PM) - Obesity, Precision Medicine Unit - US, Remote What you will do Let’s do this. Let...
including commercialization of new therapeutic products required, Rare Disease, Neuroscience and global experience... to work in our office three days per week on average. Position Summary: The Senior Manager, Commercial Launch Excellence...
products required, Rare Disease, Neuroscience and global experience a plus Understanding of the commercial process and the... in our office three days per week on average. Position Summary: The Senior Manager, Commercial Launch Excellence, Strategy...
diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach.... Observational Research, Senior Manager (Obesity) What you will do Are you searching for a new and dynamic opportunity...
, 2 days remote weekly) General Summary: Vertex currently operates at the forefront of rare disease scientific...Job Description Senior Director, Market Access Strategy - Type 1 Diabetes (T1D) Location: Boston, MA (3 days onsite...
diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach.... R&D Portfolio Forecasting and Analysis Sr. Manager What you will do Let’s do this. Let’s change the world...
weekly) General Summary: Vertex currently operates at the forefront of rare disease scientific innovation... and resources to maximize access and uptake for the commercialization of the T1D program, currently in late -stage development...
and post-launch Any of the following experiences would be a plus: rare disease, building new markets/new therapeutic area... portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections, in addition...